“Autistic disorders (ADs) are heterogeneous neurodevelopmental disorders arised by the interaction of genes and environmental factors. Dysfunctions in social interaction and communication skills, repetitive and stereotypic verbal and non-verbal behaviours are common features of ADs.
There are no defined mechanisms of pathogenesis, rendering curative therapy very difficult…
In this study, we investigated the involvement of cannabinoid system…
Our data indicate CB2 receptor as potential therapeutic target for the pharmacological management of the autism care.”